Lowering Low-Density Lipoprotein Cholesterol: Statins, Ezetimibe, Bile Acid Sequestrants, and Combinations: Comparative Efficacy and Safety-Reference-Cited by-同舟云学术

Lowering Low-Density Lipoprotein Cholesterol: Statins, Ezetimibe, Bile Acid Sequestrants, and Combinations: Comparative Efficacy and Safety

Published:2009-03 Issue:1 Volume:38 Page:79-97
ISSN:0889-8529
Container-title:Endocrinology and Metabolism Clinics of North America
language:en
Short-container-title:Endocrinology and Metabolism Clinics of North America

Author:

Hou Runhua,Goldberg Anne Carol

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Reference98 articles.

1. Lipids, diabetes, and coronary heart disease: insights from the Framingham study;Kannel;Am Heart J,1985

2. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention trial;Stamler;Diabetes Care,1993

3. The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease;JAMA,1984

4. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S);Lancet,1994

5. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group;Shepherd;N Engl J Med,1995

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis of cholesterol analogues and comparison on their effect on plasma cholesterol with β-Sitosterol;Food Chemistry;2024-12

2. Research Progress in the Clinical Treatment of Familial Hypercholesterolemia;Current Medicinal Chemistry;2024-03

3. Bioactive plant molecules, sources, and mechanisms of action in the treatment of cardiovascular diseases;Pharmacognosy;2024

4. Hypolipidemic activity of the polysaccharide L-rhamnopyranosyl-6-O-methyl-galacturonan in combined administration with HMG-CoA reductase and cholesterol absorption inhibitors;Drug development & registration;2022-08-28

5. Outcome-Based Reimbursement: The Solution to High Drug Spending?;Manufacturing & Service Operations Management;2022-07